Cargando…
Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
Autores principales: | Bayraktaroğlu, Taner, Barut, Figen, Çakmak, Güldeniz Karadeniz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298178/ https://www.ncbi.nlm.nih.gov/pubmed/37383392 http://dx.doi.org/10.3389/fendo.2023.1209776 |
Ejemplares similares
-
The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk
por: Alshahrani, Awad S, et al.
Publicado: (2021) -
Clinicopathological factors increased the risk of malignancy in thyroid nodules with atypical or follicular lesions of undetermined significance (AUS/FLUS) risk factor of malignancy in thyroid nodule with AUS/FLUS
por: Hong, In Ki, et al.
Publicado: (2016) -
Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation
por: Huhtamella, Roope, et al.
Publicado: (2019) -
Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022) -
Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques
por: Kim, Tae Hyuk, et al.
Publicado: (2016)